KLAC · KLA Corporation · Stock research

ย# KLAC — KLA Corporation

Current Thesis

KLA sits at the toll booth on rising chip complexity. It holds roughly 58% of the wafer process-control market at about 7.5x the nearest competitor (Q3 FY2026 slides), and every incremental custom-silicon design start — hyperscaler ASICs routed through Broadcom and Marvell for Google, Meta, Amazon and Microsoft — raises inspection and metrology intensity per wafer no matter whose chip ships. The fundamental narrative is still ACCELERATING. The tape is not. July has been the worst month for semiconductor stocks since 2008 (2026-07-17), and the complex-wide drawdown has dragged process-control down with memory and foundry names that carry far more cyclical beta. That divergence — a widening moat sold at the same velocity as commodity capex — is the setup worth tracking. What it is not, right now, is an entry window: Q4 FY2026 prints 2026-07-23, three trading days out, and it is the binary test of management's second-half-acceleration guide.

Bullish and bearish views on KLA Corporation

The model's bull view on KLA Corporation (KLAC), in brief: Q3 FY2026 beat (2026-04-30, quarter ended 2026-03-31): revenue $3.415B, +11% YoY and +4% QoQ; gross margin 62.2%, 45bps above the guided midpoint; operating margin 42.6%; service revenue $775M, +16% YoY; free cash flow $622M in the quarter. The bear view: The July PT cluster is below the June PT cluster. Both cases follow in full.

Bull Case

• Q3 FY2026 beat (2026-04-30, quarter ended 2026-03-31): revenue $3.415B, +11% YoY and +4% QoQ; gross margin 62.2%, 45bps above the guided midpoint; operating margin 42.6%; service revenue $775M, +16% YoY; free cash flow $622M in the quarter.
• Q4 FY2026 guide: revenue $3.575B ±$200M, another sequential step up, with full-year CY2026 guided to high-teens YoY growth weighted to the second half (2026-04-30 call).
• Share gain, not just cycle beta: process-control share ~58%, up roughly 80bps, at ~7.5x the nearest rival. Service is the annuity layer — installed-base revenue compounding at mid-teens regardless of tool-order timing.
• Advanced packaging inflection: systems revenue near $950M with over 70% YoY growth in CY2025, tracking toward ~$1B. HBM stacking and 2.5D/3D integration are structural demand, not a capex pulse.
• Sell side is raising into the drawdown, which is unusual: Morgan Stanley Overweight $274 (2026-07-06), TD Cowen Buy $260 (2026-07-09), Needham Buy $270 and Stifel Buy $270 (both 2026-07-10), UBS $255 (2026-07-15), Oppenheimer Outperform $260 (2026-07-16). Six target raises in eleven days during the worst semi month in eighteen years is a genuine signal about numbers, not sentiment.
• Institutional accumulation: Daniel Loeb's Third Point added KLA, ASML and LRCX in Q1 (disclosed 2026-06-12). KLAC also surfaced in unusual options activity screens on 2026-07-15.

Bear Case

• The July PT cluster is below the June PT cluster. Wells Fargo $305 (2026-06-22), BofA $317 (2026-06-23) and Cantor $325 (2026-06-29) sat far higher than the $255–274 band the marginal analyst is now marking. Six "raises" that collectively reset the consensus ceiling roughly 15–20% lower is a downgrade dressed as an upgrade. Anyone anchoring to the $325 print is anchoring to a stale number.
• Peak multiple against a cyclical denominator. Forward P/E in the ~50x zone versus an 18–25x historical band. WFE earnings are cycle earnings; a rich multiple applied to peak EPS carries derating risk on both terms simultaneously if capex intentions soften.
• Complex-wide risk-off overwhelms single-name quality. Three separate routs since late June — 2026-06-23, the 4.5% semi drop on 2026-07-01/02, and the month-long grind flagged 2026-07-17. Process-control's defensive characteristics have not insulated it.
• The retail-attention stack keeps building. "$1,000 invested 15 years ago" (2026-06-12), "5-year returns, 50.7% annualized" (2026-07-02), "$100 invested 10 years ago" (2026-07-16). Three backward-looking return pieces in five weeks, layered on 10:1 split euphoria, is what a story going mainstream looks like.
• Binary event in three trading days with no fresh fundamental data arriving before it.

Setup & Price Structure

The split-day high near $254.54 on 2026-06-12 marked the top of the post-split enthusiasm leg; market cap was $316.04B on 2026-07-02 on the way down. Price has since spent most of July working lower with the complex, which puts it back inside — rather than above — the $255–274 target band the July analyst cohort has settled on. That restores a modest sell-side margin of safety that did not exist in mid-June, when price traded through every published number.

Structurally, ~$210 remains the prior consolidation shelf and first real support beneath the current range. A weekly close through it would end the post-split base and turn the pattern into a lower-highs sequence for the first time in this leg. Above that shelf, the drawdown reads as complex-wide de-risking rather than a change in KLA's demand curve.

Two things argue against buying the dip mechanically here. First, the earnings blackout: fresh exposure taken between now and 2026-07-23 is a directional wager on guidance language, not a trend entry. Second, cluster confirmation is absent — AMAT, LRCX and ASML are all in drawdown together, so there is no peer-breakout signature to lean on. KLA running alone on split mechanics would be suspect; KLA falling alongside the group is simply beta. Neither is a setup.

The reset is worth respecting on the other side of the print. A clean version of this trade is the gap-and-hold: guidance confirms high-teens with second-half weighting, the stock holds its post-print low for several sessions, and the entry is taken on the reclaim rather than into the event.

Catalyst Calendar (next 30 days)

• ~2026-07-24 to 2026-07-31 (est.): post-print analyst target revisions. Watch whether the $255–274 band moves up or compresses further — that is the cleanest read on whether the June downshift was cycle-timing or estimate-cutting.
• ~2026-08-05 (est.): quarterly dividend declaration, following the 21% hike already in the tape.
• Ongoing: WFE peer prints — LRCX and AMAT report inside the same window and set the sector tone KLA trades against.

Elapsed catalysts

• 2026-07-23 (confirmed): Q4 FY2026 earnings, quarter ended 2026-06-30. Guide was $3.575B ±$200M. The number that matters more than the print is the FY2027 framing and whether "second-half acceleration" survives intact. (passed 6d ago)

What Would Change Our Mind

• A weekly close below $210 ends the post-split base and converts the July drawdown from complex beta into a structural break.
• A Q4 revenue print materially under the ~$3.575B guide midpoint, or any walk-back of second-half-acceleration language on the 2026-07-23 call, flips the theme toward saturation regardless of price.
• July target raises reversing into cuts post-print — the sell side raising numbers during a rout and then cutting them after the print would confirm the estimate cycle has rolled.
• Advanced-packaging systems revenue growth decelerating below ~40% YoY would remove the strongest secular leg of the story.
• Conversely, a print that holds the guide with an upward FY2027 frame, followed by the stock reclaiming its pre-rout range on expanding volume, is the confirmation that turns this from a watch item into a size-up candidate.

Correlation Notes

• Tight cluster: LRCX, AMAT, ASML. These four trade as one factor on WFE capex headlines; treating any two as independent exposures understates concentration meaningfully.
• Second-order: MU and the memory complex. HBM capex intentions transmit into KLA's advanced-packaging line with a lag, so Micron's guidance is a leading input.
• Demand-side: TSM, and by extension the custom-silicon designers (AVGO, MRVL). Design-start counts drive process-control intensity more directly than wafer volume does.
• Regime: the SOX and Nasdaq 100 semiconductor weighting dominate short-horizon returns. During months like July 2026, single-name fundamentals have near-zero explanatory power over five-day moves — a reason to size any post-print entry to the sector's volatility, not KLA's.